Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 20:
21. The compound of claim 20, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2 is C1-C5 alkyl, wherein the C1-C5 alkyl is substituted by 2, 3, 4, or 5 independently selected R2a substituents;
at least one R2a is OR5:
at least one R2a is phenyl, wherein the phenyl is optionally substituted by 1, 2, 3, 4, or 5 independently selected R4a substituents;
each R4a is an independently selected halogen substituent; and
R5 is H or C1-C6 alkyl.